Clinical trial Recruiting at 1 site Interventional Ages 18 to 35 Women only

Effects of melatonin on uterine contractions in pregnant women

Official title: Testing Effects of Melatonin on Uterine Contractions in Women

Run by Brigham and Women's Hospital · NCT05358834 · Data updated 2026-11-12

This study tests whether taking melatonin can change the frequency of uterine contractions in full-term pregnant women.

More Pregnant Women trials

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexWomen only
Enrollment120 (estimated)
SponsorBrigham and Women's Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJanuary 1, 2023
Main results expectedMay 30, 2027
Study endsJune 30, 2027
Registry record updatedMay 18, 2026
Trial IDNCT05358834 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are nulliparous women aged 18 to 35, with a BMI under 36, who are at least 38 weeks pregnant with a single fetus.

Probably not a fit

Patients with medical conditions or medications that contraindicate melatonin use or affect uterine contractions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the relationship between melatonin levels and uterine contractions in full-term pregnant women. It builds on previous research that explored how melatonin affects the human myometrium and uterine activity. The study will manipulate melatonin levels using exogenous melatonin during different times of the day to observe its effects on uterine contractions. Participants will be monitored to establish a causal link between melatonin and contraction frequency.

Why it matters

Potential benefit: If successful, this study could provide insights into managing uterine contractions during labor, potentially improving outcomes for mothers and infants.

How similar studies have gone: While this approach is based on recent physiological discoveries, it is relatively novel and has not been extensively tested in this specific context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* nulliparity, age between 18 and 35,
* BMI\<36 pre-pregnancy,
* ≥38 weeks of pregnancy with a single fetus at time of study.

Exclusion Criteria:

* color blind;
* prescription drugs affecting sleep, melatonin, and/or circadian rhythms (e.g., beta blockers, non-steroidal anti-inflammatory drugs);
* a health or pregnancy related condition that might affect melatonin or uterine contractions;
* medical conditions or medications for which melatonin might be contraindicated or there may be a drug interactions (e.g., Central Nervous System depressants/sedatives, Fluvoxamin (Luvox), medications for diabetes, immunosuppressants, anti-coagulants, Nifedipine, Verapamil).

Note: We cannot list all possible exclusionary criteria. Dr. Carolina Bibbo (co-I), our Obstetrics Investigator at Brigham and Women's Hospital (BWH), will make final determination of suitability including any safety concerns for each potential participant.

Where it's running

  • Brigham and Women's Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.